WaveMan · Form 4
Donovan Joanne M. insider trades
> Search tickers & screens ⌘K
LIVE

Donovan Joanne M. insider trades

Donovan Joanne M. has filed 17 Form 4s with the SEC that we hold, all for Edgewise Therapeutics, Inc. (EWTX), as CMO. Across all of them we count 0 purchases worth $0 and 17 sales worth $5.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 11 sales ($4.6M). The largest single trade was a sale of 50,000 shares of Edgewise Therapeutics, Inc. worth $1.9M, dated 2026-05-05. The first filing on our record is dated 2021-08-19 and the latest 2026-08-17.

Edgewise Therapeutics, Inc. (EWTX)

CMO · 17 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-02S, sale reported on Form 43,254$29.0K2023-05-03
2024-05-02S, sale reported on Form 43,682$69.6K2024-05-03
2024-09-20S, sale reported on Form 47,162$202.6K2024-09-24
2025-01-28S, sale reported on Form 425,000$690.8K2025-01-30
2025-05-02S, sale reported on Form 45,187$85.3K2025-05-07
2025-08-12S, sale reported on Form 42,862$38.3K2025-08-14
2026-03-27S, sale reported on Form 49,623$298.1K2026-03-30
2026-03-27S, sale reported on Form 46,735$208.7K2026-03-30
2026-03-31S, sale reported on Form 421,338$685.4K2026-03-31
2026-04-01S, sale reported on Form 428,662$926.1K2026-04-02
2026-05-04S, sale reported on Form 45,230$163.6K2026-05-05
2026-05-05S, sale reported on Form 450,000$1.9M2026-05-05
2026-08-12S, sale reported on Form 42,839$124.3K2026-08-14
2026-08-12S, sale reported on Form 42,779$121.5K2026-08-14
2026-08-12S, sale reported on Form 4104$4.6K2026-08-14
2026-08-12S, sale reported on Form 4800$35.6K2026-08-14
2026-08-13S, sale reported on Form 42,919$126.7K2026-08-14
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1644087) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms